If we get 2 deals inside the month, 20c could be revisited.
CD40L is pretty mature. If it is this or the next deal there should be a substantial sp rise.
SClurnge suggested it could be the 2nd stage to Roche.
In the trading halt for the Roche deal, Roche were refered to as "a large pharmaceutical and biotechnology group".
This trading halt again has "a large pharmaceutical and biotechnology group".
maximising valuation, page-5
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $466.6M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.8¢ | $519.2K | 5.169M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 182466 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 101115 | 2 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |